Darnerud P O, Biessmann A, Brandt I
Arch Toxicol. 1982 Sep;50(3-4):217-26. doi: 10.1007/BF00310853.
The disposition of three [1-14C]-chlorododecanes (MCDD, PCDD I and PCDD II; 17.4%, 55.9%, and 68.5% chlorination) was studied in C57Bl mice. [1-14C]-lauric acid (LA) was studied as reference compound. Fifty-two percent (MCDD), 32% (PCDD I), and 8% (PCDD II) of the radioactive doses were exhaled as 14CO2 during 12 h after i.v. injection. Similar results were obtained after p.o. administration. In addition to a marked labelling of the liver and fat, the distribution patterns observed at 24 h after administration revealed an uptake of radioactivity in tissues with high cell turnover/high metabolic activity, e.g., intestinal mucosa, bone marrow, salivary glands and thymus. The concentration of radioactivity in these sites and the exhalation of 14CO2, which were inverse to the degree of chlorination, indicate that the chloroalkanes are degraded to metabolites which can be utilized in the intermediary metabolism. A similar, although more pronounced, distribution pattern and 14CO-2-exhalation (70% of i.v. dose) was observed after LA administration. The long time retention of heptane-soluble radioactivity in liver and fat (indicating unmetabolized substance) increased with degree of chlorination. On the contrary, the administration of LA and the chlorododecanes MCDD and PCDD I, but not of PCDD II, resulted in a selective labelling of the central nervous system 30-60 days after injection.
在C57Bl小鼠中研究了三种[1-¹⁴C] - 氯代十二烷(MCDD、PCDD I和PCDD II;氯化程度分别为17.4%、55.9%和68.5%)的处置情况。[1-¹⁴C] - 月桂酸(LA)作为参考化合物进行了研究。静脉注射后12小时内,52%(MCDD)、32%(PCDD I)和8%(PCDD II)的放射性剂量以¹⁴CO₂形式呼出。口服给药后也得到了类似结果。除了肝脏和脂肪有明显标记外,给药后24小时观察到的分布模式显示,在细胞更新率高/代谢活性高的组织,如肠黏膜、骨髓、唾液腺和胸腺中也有放射性摄取。这些部位的放射性浓度以及¹⁴CO₂的呼出情况与氯化程度呈反比,表明氯代烷烃被降解为可用于中间代谢的代谢产物。LA给药后观察到类似但更明显的分布模式和¹⁴CO₂呼出情况(静脉注射剂量的70%)。肝脏和脂肪中庚烷可溶的放射性(表明未代谢的物质)的长时间滞留随着氯化程度的增加而增加。相反,LA、氯代十二烷MCDD和PCDD I给药后,而非PCDD II给药后,在注射后30 - 60天导致中枢神经系统有选择性标记。